Endocannabinoid System Targeted Therapeutics Market, Global Outlook and Forecast 2022-2028

February 2022 | 69 pages | ID: E49257CF65D5EN
Market Monitor Global

Abstracts

Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases

This report contains market size and forecasts of Endocannabinoid System Targeted Therapeutics in Global, including the following market information:

Global Endocannabinoid System Targeted Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Endocannabinoid System Targeted Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Endocannabinoid System Targeted Therapeutics include GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals and Therapix Biosciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Endocannabinoid System Targeted Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Endocannabinoid System Targeted Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Oral
• Inhalation
• Others

Global Endocannabinoid System Targeted Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Autoimmune Disorders
• Genetic Disorders
• Neurological Disorders
• Pain Disorders

Global Endocannabinoid System Targeted Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Endocannabinoid System Targeted Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Endocannabinoid System Targeted Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Endocannabinoid System Targeted Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GW Pharmaceuticals
• MAKScientific
• Corbus Pharmaceuticals
• Tilray
• Pure Green
• Avicanna
• GB Sciences
• Botanix Pharmaceuticals
• Therapix Biosciences
• Zelira Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Endocannabinoid System Targeted Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Endocannabinoid System Targeted Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Endocannabinoid System Targeted Therapeutics Market Size: 2021 VS 2028
2.2 Global Endocannabinoid System Targeted Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Endocannabinoid System Targeted Therapeutics Players in Global Market
3.2 Top Global Endocannabinoid System Targeted Therapeutics Companies Ranked by Revenue
3.3 Global Endocannabinoid System Targeted Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Endocannabinoid System Targeted Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Endocannabinoid System Targeted Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endocannabinoid System Targeted Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Endocannabinoid System Targeted Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Endocannabinoid System Targeted Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Endocannabinoid System Targeted Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Inhalation
  4.1.4 Others
4.2 By Type - Global Endocannabinoid System Targeted Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Endocannabinoid System Targeted Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Endocannabinoid System Targeted Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Endocannabinoid System Targeted Therapeutics Market Size, 2021 & 2028
  5.1.2 Autoimmune Disorders
  5.1.3 Genetic Disorders
  5.1.4 Neurological Disorders
  5.1.5 Pain Disorders
5.2 By Application - Global Endocannabinoid System Targeted Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Endocannabinoid System Targeted Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Endocannabinoid System Targeted Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Endocannabinoid System Targeted Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Endocannabinoid System Targeted Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Endocannabinoid System Targeted Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Endocannabinoid System Targeted Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028
  6.3.2 US Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.3.3 Canada Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028
  6.4.2 Germany Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.3 France Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.5 Italy Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.6 Russia Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028
  6.5.2 China Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.5.3 Japan Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.5.6 India Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.7.3 Israel Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028
  6.7.5 UAE Endocannabinoid System Targeted Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GW Pharmaceuticals
  7.1.1 GW Pharmaceuticals Corporate Summary
  7.1.2 GW Pharmaceuticals Business Overview
  7.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.1.4 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 GW Pharmaceuticals Key News
7.2 MAKScientific
  7.2.1 MAKScientific Corporate Summary
  7.2.2 MAKScientific Business Overview
  7.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.2.4 MAKScientific Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 MAKScientific Key News
7.3 Corbus Pharmaceuticals
  7.3.1 Corbus Pharmaceuticals Corporate Summary
  7.3.2 Corbus Pharmaceuticals Business Overview
  7.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.3.4 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Corbus Pharmaceuticals Key News
7.4 Tilray
  7.4.1 Tilray Corporate Summary
  7.4.2 Tilray Business Overview
  7.4.3 Tilray Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.4.4 Tilray Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Tilray Key News
7.5 Pure Green
  7.5.1 Pure Green Corporate Summary
  7.5.2 Pure Green Business Overview
  7.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.5.4 Pure Green Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Pure Green Key News
7.6 Avicanna
  7.6.1 Avicanna Corporate Summary
  7.6.2 Avicanna Business Overview
  7.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.6.4 Avicanna Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Avicanna Key News
7.7 GB Sciences
  7.7.1 GB Sciences Corporate Summary
  7.7.2 GB Sciences Business Overview
  7.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.7.4 GB Sciences Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 GB Sciences Key News
7.8 Botanix Pharmaceuticals
  7.8.1 Botanix Pharmaceuticals Corporate Summary
  7.8.2 Botanix Pharmaceuticals Business Overview
  7.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.8.4 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Botanix Pharmaceuticals Key News
7.9 Therapix Biosciences
  7.9.1 Therapix Biosciences Corporate Summary
  7.9.2 Therapix Biosciences Business Overview
  7.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.9.4 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Therapix Biosciences Key News
7.10 Zelira Therapeutics
  7.10.1 Zelira Therapeutics Corporate Summary
  7.10.2 Zelira Therapeutics Business Overview
  7.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Major Product Offerings
  7.10.4 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Zelira Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Endocannabinoid System Targeted Therapeutics Market Opportunities & Trends in Global Market
Table 2. Endocannabinoid System Targeted Therapeutics Market Drivers in Global Market
Table 3. Endocannabinoid System Targeted Therapeutics Market Restraints in Global Market
Table 4. Key Players of Endocannabinoid System Targeted Therapeutics in Global Market
Table 5. Top Endocannabinoid System Targeted Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Endocannabinoid System Targeted Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Endocannabinoid System Targeted Therapeutics Product Type
Table 9. List of Global Tier 1 Endocannabinoid System Targeted Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endocannabinoid System Targeted Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Endocannabinoid System Targeted Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Endocannabinoid System Targeted Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Endocannabinoid System Targeted Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Endocannabinoid System Targeted Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GW Pharmaceuticals Corporate Summary
Table 31. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offerings
Table 32. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. MAKScientific Corporate Summary
Table 34. MAKScientific Endocannabinoid System Targeted Therapeutics Product Offerings
Table 35. MAKScientific Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Corbus Pharmaceuticals Corporate Summary
Table 37. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offerings
Table 38. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Tilray Corporate Summary
Table 40. Tilray Endocannabinoid System Targeted Therapeutics Product Offerings
Table 41. Tilray Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Pure Green Corporate Summary
Table 43. Pure Green Endocannabinoid System Targeted Therapeutics Product Offerings
Table 44. Pure Green Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Avicanna Corporate Summary
Table 46. Avicanna Endocannabinoid System Targeted Therapeutics Product Offerings
Table 47. Avicanna Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. GB Sciences Corporate Summary
Table 49. GB Sciences Endocannabinoid System Targeted Therapeutics Product Offerings
Table 50. GB Sciences Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Botanix Pharmaceuticals Corporate Summary
Table 52. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Offerings
Table 53. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Therapix Biosciences Corporate Summary
Table 55. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Offerings
Table 56. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Zelira Therapeutics Corporate Summary
Table 58. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Offerings
Table 59. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Endocannabinoid System Targeted Therapeutics Segment by Type in 2021
Figure 2. Endocannabinoid System Targeted Therapeutics Segment by Application in 2021
Figure 3. Global Endocannabinoid System Targeted Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Endocannabinoid System Targeted Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2021
Figure 8. By Type - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Endocannabinoid System Targeted Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Endocannabinoid System Targeted Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MAKScientific Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Tilray Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pure Green Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Avicanna Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GB Sciences Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)